Skeletal deterioration induced by RANKL infusion: a model for high-turnover bone disease

Author： Yuan Y.   Kostenuik P.   Ominsky M.   Morony S.   Adamu S.   Simionescu D.   Basalyga D.   Asuncion F.   Bateman T.  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.19, Iss.5, 2008-05, pp. : 625-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids

By Devogelaer Jean-Pierre  

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 1058-1069

Oxford University Press

Access to resources Recommend Favorite

MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model

By              

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1417-1423

Spandidos Publications

Access to resources Recommend Favorite

Changes in Bone Turnover, Bone Mineral and Fracture Risk Induced by Drugs Used to Treat Epilepsy

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-09 ,pp. : 168-172

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemical markers of bone turnover

By Carey John   Licata Angelo   Delaney Miriam  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 3, 2006-09 ,pp. : 197-211

Humana Press, Inc

Access to resources Recommend Favorite

Bone turnover in hyperparathyroidism

By Kerschan-Schindl Katharina  

Wiener Medizinische Wochenschrift, Vol. 163, Iss. 17-18, 2013-09 ,pp. : 391-396

Springer Publishing Company

Access to resources Recommend Favorite